Treating Gulf War Illness with Novel Anti-Inflammatories: A Screening of Botantical Microglia Modulators

Abstract

On June 30, 2015, we obtained final IRB approval and an IND exemption determination from UAB IRB. All approved documents (consent form, human subject protocol and attachments) were forwarded to ORP HRPO for final approval on July 2, 2015. While awaiting final ORP HRPO approval we have worked to establish collaborations with Birmingham and Alabama VA support groups for recruitment purposes. We have also established a great rapport with the nursing staff at the UAB Clinical Research Unit (CRU) where the study will be conducted. We have selected personnel to run the study and started training on the UAB IRB process, regulatory document preparation, review and submission. Upon the receipt of the final IRB ORP HRPO approval, we will initiate recruitment advertising, participant screening, enrollment and the study protocol.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2015
Accession Number
AD1005095

Entities

People

  • Jarred Younger
  • Lisa Smoot

Organizations

  • University of Alabama at Birmingham

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Biological Markers
  • Biomedical Research
  • Department Of Defense
  • Electronic Mail
  • Information Operations
  • Management Personnel
  • Modulators
  • Neuroglia
  • Persian Gulf Syndrome
  • Recruiting
  • Students
  • Teamwork
  • Universities

Readers

  • Clinical Trial Research.